Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBiohaven Pharmaceutical Holding Company Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$1.55 | -$1.55 | -$1.55 |
| Q2 2024 | 4 | -$1.78 | -$1.78 | -$1.78 |
| Q3 2024 | 2 | -$1.70 | -$1.70 | -$1.70 |
| Q4 2024 | 6 | -$2.10 | -$0.59 | -$1.60 |
| Q1 2025 | 3 | -$1.97 | -$1.40 | -$1.70 |
| Q2 2025 | 2 | -$1.67 | -$1.67 | -$1.67 |
| Q3 2025 | 2 | -$1.65 | -$1.65 | -$1.65 |
| Q4 2025 | 2 | -$1.68 | -$1.68 | -$1.68 |
| Q1 2026 | 1 | -$1.58 | -$1.58 | -$1.58 |
| Q2 2026 | 1 | -$1.51 | -$1.51 | -$1.51 |
| Q3 2026 | 1 | -$1.49 | -$1.49 | -$1.49 |
| Q4 2026 | 1 | -$1.47 | -$1.47 | -$1.47 |
Biohaven Pharmaceutical Holding Company Ltd. Earnings Date And Information
Biohaven Pharmaceutical Holding Company Ltd. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-1.7 earnings per share for the quarter, missing analysts' consensus estimates of $-1.7 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Biohaven Pharmaceutical Holding Company Ltd. has generated $-6 earnings per share over the last year ($-5.73 diluted earnings per share) and currently has a price-to-earnings ratio of -4.3. Biohaven Pharmaceutical Holding Company Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Biohaven Pharmaceutical Holding Company Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.70 | -$1.70 | 0 | $1,667 | $0 |
| 08/09/2024 | Q2 2024 | -$3.64 | $0 | $0 | ||
| 05/09/2024 | Q1 2024 | -$1.50 | -$2.20 | -0.7 | $0 | |
| 12/30/2023 | Q4 2023 | -$1.81 | $0 | |||
| 11/14/2023 | Q3 2023 | -$1.33 | -$1.50 | -0.17 | $0 | |
| 07/31/2023 | Q2 2023 | -$1.24 | -$1.32 | -0.08 | $0 | |
| 05/12/2023 | Q1 2023 | -$1.39 | -$1.03 | 0.36 | $0 | |
| 03/23/2023 | Q4 2022 | -$1.24 | -$3.30 | -2.06 | $-215,079,000 | |
| 11/09/2022 | Q3 2022 | -$2.53 | -$1.75 | 0.78 | $0 | |
| 08/05/2022 | Q2 2022 | -$2.79 | -$5.67 | -2.88 | $215.08 M | |
| 05/10/2022 | Q1 2022 | -$2.52 | -$2.71 | -0.19 | $318.85 M | |
| 02/25/2022 | Q4 2021 | -$2.07 | -$1.45 | 0.62 | $190.01 M | |
| 11/09/2021 | Q3 2021 | -$2.44 | -$1.52 | 0.92 | $135.74 M | |
| 08/09/2021 | Q2 2021 | -$2.77 | -$3.23 | -0.46 | $92.93 M | |
| 05/10/2021 | Q1 2021 | -$2.92 | -$4.27 | -1.35 | $43.82 M | |
| 03/01/2021 | Q4 2020 | -$2.89 | -$4.49 | -1.6 | $35.11 M | |
| 11/09/2020 | Q3 2020 | -$2.74 | -$3.27 | -0.53 | $17.66 M | |
| 08/10/2020 | Q2 2020 | -$2.78 | -$3.08 | -0.3 | $9.70 M | |
| 05/07/2020 | Q1 2020 | -$2.28 | -$3.07 | -0.79 | $1.15 M | |
| 02/25/2020 | Q4 2019 | -$0.00 | $0 |
Biohaven Pharmaceutical Holding Company Ltd. Earnings: FAQ's
When is Biohaven Pharmaceutical Holding Company Ltd.'s earnings date?
Biohaven Pharmaceutical Holding Company Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
How can I listen to Biohaven Pharmaceutical Holding Company Ltd.'s earnings conference
call?
The conference call for Biohaven Pharmaceutical Holding Company Ltd.'s latest earnings report can be listened to online.
How can I read Biohaven Pharmaceutical Holding Company Ltd.'s conference call transcript?
The conference call transcript for Biohaven Pharmaceutical Holding Company Ltd.'s latest earnings report can be read online.
How much profit does Biohaven Pharmaceutical Holding Company Ltd. generate each year?
Biohaven Pharmaceutical Holding Company Ltd. (:BHVN) has a recorded net income of $0. Biohaven Pharmaceutical Holding Company Ltd. has generated $-5.73 earnings per share over the last four quarters.
What is Biohaven Pharmaceutical Holding Company Ltd.'s price-to-earnings ratio?
Biohaven Pharmaceutical Holding Company Ltd. (:BHVN) has a price-to-earnings ratio of -4.3 and price/earnings-to-growth ratio is 1.97.